Answers are grounded in this paper and cite their sources.
Findings reveal NLRP12 enhances osteogenic differentiation while reducing inflammation in PDLSCs, indicating potential therapeutic targeting.
NLRP12 suppressed inflammatory responses while enhancing osteogenic differentiation of PDLSCs via downregulating the activation of the nuclear factor kappa-B pathway, indicating that NLRP12 is a latent target for enhancing PDLSCs-based periodontal tissue regeneration.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: